HemoGenyx Pharmaceuticals Plc (GB:HEMO)
LSE:HEMO
Holding GB:HEMO?
Track your performance easily

HemoGenyx Pharmaceuticals Plc (HEMO) Cash flow

15 Followers

HemoGenyx Pharmaceuticals Plc Cash Flow

GB:HEMO's free cash flow for Q2 2022 was £―. For the 2022 fiscal year, GB:HEMO's free cash flow was decreased by £-703.25K and operating cash flow was £―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
-£ -2.90M£ -2.63M£ -1.80M£ -1.20M£ -1.35M
Investing Cash Flow
-£ -420.25K£ -938.95K£ -169.68K£ 2.27K£ -20.22K
Financing Cash Flow
-£ -110.14K£ 8.78M£ 3.21M£ -39.39K£ 1.18M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-£ 2.53M£ 6.84M£ 1.81M£ 498.68K£ 1.76M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
---£ 35.07K-£ 4.99K
Issuance Of Debt
-£ -110.14K£ 8.82M£ 3.61M-£ 1.18M
Repayment Of Debt
-£ -110.14K£ -3.18M---
Free Cash Flow
-£ -3.33M£ -2.63M£ -1.80M£ -1.20M£ -1.35M
Domestic Sales
------
Foreign Sales
------
Currency in GBP

HemoGenyx Pharmaceuticals Plc Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis